# OnCo record modex-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/modex-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "modex-therapeutics" ;
  schema:name "ModeX Therapeutics"@en ;
  schema:alternateName "ModeX Therapeutics, An OPKO Health Company"@en ;
  schema:description "ModeX Therapeutics is a US-based biotechnology company that leads 2 cancer trials in OnCo, testing the tetraspecific T-cell engagers MDX2001 and MDX2003 in biliary tract cancer, cervical cancer, colorectal cancer and endometrial cancer."@en ;
  schema:url <https://onco.cc/companies/modex-therapeutics/>, <https://www.modextherapeutics.com> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.modextherapeutics.com>, <https://clinicaltrials.gov/search?lead=ModeX%20Therapeutics%2C%20An%20OPKO%20Health%20Company> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/waldenstrom/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/follicular-lymphoma/> ;
  onco:trials <https://onco.cc/trials/nct06239194/>, <https://onco.cc/trials/nct07249905/> .